Le Lézard
Classified in: Health, Science and technology, Business
Subject: BOARD OF DIRECTORS

Griffon Pharmaceuticals appoints Dr. Marc Cluzel to Board of Directors


MONTREAL, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Montreal-based biopharmaceutical company Griffon Pharmaceuticals Inc. ("Griffon") announced today that Marc Cluzel, MD, PhD, joins the company's Board of Directors.

Dr. Cluzel is an established and accomplished R&D executive with experience advancing assets from early preclinical stage to registration in the US, Europe and Japan. He is the former EVP of Global R&D at Sanofi and is the non-executive Chairman of MorphoSys AG.

John Huss, Chairman of the Board, comments: "Dr. Cluzel's presence on our Board is yet another positive milestone for Griffon and allows the company to move forward with the clinical development of our lead compound with great confidence."

Griffon's lead compound, GP119 is a highly stable, next generation GRF-VIP analog with increased bioavailability for the treatment of excess visceral fat in HIV+ patients with lipodystrophy. It is a bifunctional peptide comprising GRF and VIP that have complimentary metabolic, cardiovascular and anti-inflammatory effects.

About Griffon Pharmaceuticals Inc.

Griffon is Montreal-based biotechnology company developing GP119, a differentiated, first-in-class bifunctional GRF-VIP analog for the treatment of excess visceral fat in HIV+ patients with lipodystrophy (LD-HIV). GP119 represents an exciting opportunity to drive treatment for patients with LD-HIV, an underserved market, with potential for expansion into new indications.

Contact Information:
Crystal Quast
Bullseye Corporate
+1-647-529-6364
[email protected] 


These press releases may also interest you

at 17:20
Petrolympic Ltd. Announces Closing of Private Placement Financing
Petrolympic Ltd. (the "Company", TSXV: PCQ) wishes to announce it has completed a non-brokered private placement (the "Offering") of 5,000,000 common shares of the Company on a flow-through basis ("FT Shares") at a price of $0.08 per FT Share, for...

at 17:15
NOVAGOLD Announces Date of its 2024 Virtual Annual General Meeting of Shareholders
NOVAGOLD's Annual General Meeting of Shareholders (the "Meeting") will be held virtually on May 16, 2024 at 1:00 p.m. PSTShareholders may vote on matters before the Meeting by proxy, join the virtual Meeting and vote, and submit questions either...

at 17:10
ECN Capital Schedules Q1-2024 Conference Call
ECN Capital Corp. ("ECN Capital" or "the Company") announced today that it intends to file its financial statements and management discussion and analysis for the three-month period ended March 31, 2024, after markets close on Thursday, May 9, 2024....

at 17:10
Gatos Silver Reports South-East Deeps Drilling Results at Cerro Los Gatos and Announces Executive Appointment
Gatos Silver, Inc. ("Gatos Silver" or the "Company") today provided an update on the drilling and exploration programs in the Los Gatos district ("LGD") in Mexico. The update includes new intercepts of mineralization in the South-East Deeps ("SE...

at 17:05
Aptar Reports First Quarter 2024 Results
AptarGroup, Inc. , a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong first quarter results driven by continued growth of the company's proprietary drug delivery systems, increased...

at 17:05
Fairfax India Renews Universal Shelf Prospectus
Fairfax India Holdings Corporation ("Fairfax India") has filed a short form base shelf prospectus with the Canadian securities regulatory authorities in connection with Fairfax India's universal shelf renewal. The shelf prospectus renewal allows...

More news about Business...


News published on and distributed by: